Aldeyra Therapeutics Inc (ALDX)

Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	44.61%3.48	2.41	4.30	5.43	8.51
Research and Development	44.61%3.48	2.41	4.30	5.43	8.51
Operating Income/Loss	64.95%-5.85	-3.55	-6.67	-8.00	-10.17
Nonoperating Income/Loss	324.43%0.40	0.09	0.21	0.31	0.40
	57.86%-5.45	-3.45	-6.46	-7.69	-9.77
Attributable To Parent	57.86%-5.45	-3.45	-6.46	-7.69	-9.77
Basic Average Shares	0.00%60.32	60.32	0.04	60.13	60.05
Diluted Average Shares	0.00%60.32	60.32	0.04	60.13	60.05
Basic Earnings Per Share	50.00%-0.09	-0.06	-0.10	-0.13	-0.16
Diluted Earnings Per Share	50.00%-0.09	-0.06	-0.10	-0.13	-0.16